Cell And Gene Therapy Analytics
-
Key Considerations For Rapid Microbial Methods For Mycoplasma Detection
5/29/2025
Learn the importance of demonstrating product specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence.
-
Manufacturing Hurdles With Viral Vectors
11/13/2023
With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and scale-up is critical. In this segment, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO share what they consider to be the most difficult challenges in vector development and manufacturing currently.
-
Digital Solutions For Accelerated Innovation
5/19/2025
In this webinar, hear how Applied Biosystems AccuSEQ software serves as an advanced digital tool that can help streamline bioanalytical processes and accelerate the delivery of life-changing therapies.
-
Innovative Contamination Control: Enabling Integrity And Efficiency
10/15/2024
An integrated approach can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.
-
Leveraging Rapid Sterility Testing To Advance Cell Therapy Production
6/23/2025
Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.
-
Scaling Viral Vectors
11/13/2023
Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.
-
Rapid Micro Methods In QC Micro Testing: A NIBRT Perspective
5/29/2025
Learn about some of the advanced Rapid Micro Method systems that are being adopted by biopharma companies worldwide, and how they are changing the face of QC Microbiological testing.
-
Validation Of A qPCR Assay For Host Cell DNA Quantitation
6/9/2025
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
-
Multi-Omics And Bioinformatics In Cell Culture Media Design
6/16/2025
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.
-
Regulatory Compliance And Viral Vectors
11/13/2023
Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.